Molecular Markers for Prostate Cancer: Analysis of miRNA Profiles as Biomarkers in Patients with High-risk Prostate Cancer

被引：0
|
作者：
Kirste, S. [1 ,2 ]
Drendel, V [3 ]
Stegmaier, P. [1 ]
Mo, X. M. [4 ]
Chakravarti, A. [2 ]
Grosu, A. [1 ]
Bell, Hlavin E. [2 ]
机构：
[1] Uniklin Freiburg, Freiburg, Germany
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Univ Freiburg Klinikum, Abt Allgemeine Pathol, Freiburg, Germany
[4] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2013年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [21] Radiotherapy and hormone therapy in patients with high-risk prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (1): : 4 - 4
  • [22] Comparative effectiveness of treatments for high-risk prostate cancer patients
    Jayadevappa, Ravishankar
    Lee, David I.
    Chhatre, Sumedha
    Guzzo, Thomas J.
    Malkowicz, Stanley B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 574.e11 - 574.e18
  • [23] Assessment of high-grade prostate cancer risk using prostate cancer biomarkers
    Stanton, Whitney N.
    Crawford, E. David
    Arangua, Paul B.
    La Rosa, Francisco G.
    van Bokhoven, Adrie
    Lucia, M. Scott
    Poage, Wendy L.
    Partin, Alan
    Maroni, Paul
    Werahera, Priya N.
    CANADIAN JOURNAL OF UROLOGY, 2020, 27 (01) : 10080 - 10085
  • [24] Radiotherapy and hormone therapy in patients with high-risk prostate cancer
    Nature Clinical Practice Oncology, 2008, 5 (1): : 8 - 8
  • [25] Toremifene could prevent prostate cancer in high-risk patients
    Nature Clinical Practice Urology, 2006, 3 (11): : 572 - 573
  • [26] WHOLE PELVIS RADIOTHERAPY IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
    Spagnoletti, Girolamo
    Marchese, Rita
    Leo, Anna Maria
    Nardella, Grazia
    Piserchia, Maria
    Rignanese, Raffaella
    Bove, Giuseppe
    ANTICANCER RESEARCH, 2012, 32 (05) : 1925 - 1925
  • [27] High-risk prostate cancer: How high is high?
    Sandler, HM
    CANCER JOURNAL, 2002, 8 (04): : 301 - 302
  • [28] Exosome-based plasma RNA biomarkers for high-risk prostate cancer
    Gaston, Sandra M.
    Skog, Johan K.
    Spieler, Benjamin
    Dal Pra, Alan
    Stoyanova, Radka
    Fischer, Christian
    Khodor, Yevgenia
    Sant, Grannum
    Yu, Seth
    Tadigotla, Vasisht
    Chakrabortty, Sudipto K.
    Punnen, Sanoj
    Pollack, Alan
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Prostate Cancer in Patients With High Prostate-Specific Antigen But Otherwise Very Low-Risk Disease Behaves Like Prostate Cancer in High-Risk Patients
    Gestaut, M. M.
    Pruszynski, J.
    Swanson, G. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E284 - E284
  • [30] Molecular markers of prostate cancer
    Bradford, Timothy J.
    Tomlins, Scott A.
    Wang, Xiaoju
    Chinnaiyan, Arul M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (06) : 538 - 551
12345